ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2

Original text here LEIDEN, Netherlands and CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation…

Friday March 22nd, 2019

All the cures for Retinitis Pigmentosa

This article aims to collect all the cures for retinitis pigmentosa found on the internet in a single list. A…

Thursday March 21st, 2019

As you hope I will continue to live

Do you really believe they will find a cure for this damn disease (RP)? This is the question I wrote…

Friday June 2nd, 2017